Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma

NCT01455493 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT01455493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01455493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for The Treatment of Recurrent or Persistent Endometrial Carcinoma
Lead sponsor
Genentech, Inc.
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2011
Completion date
January 31, 2014
Enrollment
56 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial carcinoma